Islamabad: The Drug Regulatory Authority of Pakistan and World Health Organisation have agreed to increase bilateral cooperation and support for better patient care through provision of safe, quality and efficacious medicines.
The agreement came during a meeting between DRAP chief executive officer Dr Sheikh Akhter Hussain and WHO country representative Dr Muhammad Assai here.
The two sides also agreed on the exchange of information, knowledge and education to achieve the common objective of achieving universal health.
The WHO’s representative said both the organisations had a number of common interests
He said the WHO would provide the DRAP with complete support and cooperation for improving the quality of medicines produced in the country, building the staff members’ capacity, and increasing in own performance.
The DRAP chief thanked the WHO representative for its support and expressed the hope that the bilateral cooperation would continue with the aim to improve public health and provide the people with safe, quality and efficacious medicines.
The two also agreed on cooperation for the effective implementation of the DRAP Act, 2012, and ensuring the availability of therapeutic goods on the local market.
College administration is required to appear in person to explain the details of the incident and any actions taken to...
Court observed that the TCP termed it a “shortage”, whereas the Punjab trading agency claims that a substantial...
Anti-Terrorism Special Court Judge Malik Ijaz Asif also announced 32 years in jail and a fine of Rs0.5 million for the...
Two-day conference at the King Abdullah Campus of UAJK aims to chart a course towards sustainable economic growth and...
In Hub, environmental sample was collected on April 17, 2024 from the ‘Jumma Khan Bazar Pul’ environmental sample...
President highlighted that Pakistan was committed to regional connectivity, and the Central Asian countries needed to...